We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant

Delisted

WGSWW was delisted on the 21st of July, 2026.

27 hedge funds and large institutions have $3.74M invested in GeneDx Holdings Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2727 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

57% less capital invested

Capital invested by funds: $8.77M → $3.74M (-$5.02M)

Holders
27
Holders Change
Holders Change %
0%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
6
Closed
1
Calls
$70K
Puts
Net Calls
+$70K
Net Calls Change
-$129K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
26
Aristeia Capital
Connecticut
-$35K -53,467 Closed

WGSWW Hedge Fund Activity: Q2 2022 in Review

27 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2022, worth a combined $3.74M — down 57% from $8.77M a quarter earlier.

Fund positioning in WGSWW was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 6 trimmed.

The largest buyer was UBS Group, adding an estimated $30.4K. The largest seller was Aristeia Capital, exiting entirely with an estimated $35K sold.

  • 27 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $3.74M of GeneDx Holdings Warrant stock for Q2 2022, down 57% quarter-over-quarter.
  • 1 fund opened new GeneDx Holdings Warrant positions in Q2 2022 and 1 closed out, a net change of 0 holders.
  • The largest GeneDx Holdings Warrant buyer in Q2 2022 was UBS Group, an estimated $30.4K added.
  • The largest GeneDx Holdings Warrant seller in Q2 2022 was Aristeia Capital, an estimated $35K sold.

Based on aggregated 13F filings for Q2 2022.